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A B S T R A C T
Optoacoustic imaging (OAI) can detect haemoglobin and assess its oxygenation. However, the lack of a
haemoglobin signal need not indicate a lack of perfusion. This study uses a novel method to assist the co-
registration of optoacoustic images with dynamic contrast enhanced ultrasound (DCE-US) images to
demonstrate, in preclinical tumour models, the value of combining haemoglobin imaging with a
perfusion imaging method, showing that a lack of a haemoglobin signal does not necessarily indicate an
absence of perfusion. DCE-US was chosen for this particular experiment because US is extremely
sensitive to microbubble contrast agents and because microbubbles, like red blood cells but unlike
currently available optical contrast agents, do not extravasate. Signiﬁcant spatial correlations were
revealed between the DCE-US properties and tumour blood-oxygen saturation and haemoglobin, as
estimated using OAI. It is speculated that DCE-US properties could be applied as surrogate biomarkers for
hypoxia when planning clinical radiotherapy or chemotherapy.
© 2017 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Hypoxia is prevalent in most malignant human cancers because
the functionally abnormal tumour vasculature is not able to meet
the excessive oxygen consumption needs of the proliferating
tumour cells. This stimulates several compensatory biological
processes, which alter gene expression proﬁles [1,2] that lead to
metastasis and cancer progression [3,4], and enable a tumour to
circumvent chemo- [5] and radiotherapy [6]. It has been widely
established that the hypoxic state of a tumour can inﬂuence
treatment outcome [7–10]. In addition, hypoxia-targeted therapies
are under development and in clinical trial [11]. Therefore, for a
number of reasons, there is an urgent need for a diagnostic method
for determining whether a tumour is hypoxic, so as to enable
hypoxia-based treatment individualisation [11].
Commonly used methods for assessing tissue hypoxia in
patients are needle electrode polarography, for direct measure-
ment of tumour oxygen saturation, and needle biopsies, for
quantifying biomolecules expressed under hypoxic conditions
[11]. Both these techniques are invasive and do not represent the
whole tumour, which is likely to be crucial for planning treatment.* Corresponding author.
E-mail address: Anant.Shah@icr.ac.uk (A. Shah).
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2213-5979/© 2017 Published by Elsevier GmbH. This is an open access article under thNon-invasive imaging techniques for assessing hypoxia are
therefore under development and investigation. However, trac-
er-based hypoxia imaging methods such as phosphorescence
quenching [12], electron paramagnetic resonance [13] and
positron emission tomography [11] are of limited value due to
restricted access of the imaging probes to the hypoxic regions.
Other imaging modalities provide ways to infer hypoxia and its
spatial and temporal variation by quantifying the haemodynamics
of tissue perfusion, total haemoglobin (HbT) or blood oxygen
saturation (SaO2), each with its own limitations [11].
Quantitative SaO2 imaging is particularly challenging. For
example, blood oxygen level dependent magnetic resonance
imaging (BOLD MRI) is only sensitive to differences between
two states of the proportion of deoxy-haemoglobin (Hb) present,
rather than an absolute level of oxygenation. In tumour studies, the
change of state is achieved by changing the level of oxygen in the
gas breathed [14]. Diffuse optical spectroscopic imaging [15] is in
principle able to overcome this difﬁculty by using recognisable
properties of the wavelength dependence of optical absorption in
Hb and oxy-haemoglobin (HbO2) to make absolute measurements
of Hb and HbO2. However, it is accompanied by depth-dependent
low spatial resolution due to scattering of photons by tissue,
leading to difﬁculty in interpretation of blood SaO2 or HbT values.
This method works best when one can transmit light entirelye CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
16 A. Shah et al. / Photoacoustics 8 (2017) 15–27through the body part to be imaged and therefore its application
has largely been limited to breast imaging [16–18].
Multispectral optoacoustic imaging also uses the spectroscopic
absorption signatures of HbO2 and Hb to make absolute measure-
ments of HbT and SaO2 but is able to do this with a high spatial
resolution (determined by acoustic wave focusing) without the
problems associated with photon scattering and without needing
to transmit light entirely through the body [19–21]. The measure-
ments do, however, depend on the system’s sensitivity to identify
Hb and HbO2, which is affected by depth-dependent signal to noise
ratio, the spectral dependence of light attenuation in intervening
tissue and the presence of other chromophores (for example oxy-
and deoxy-myoglobin [22]). Additionally, “discrete sampling
issues” and “imperfectness in the reconstruction algorithm”, as
reported by Ding et al. [23], could also result in the appearance of
ambiguous negative values that would make the spectral
recognition of Hb and/or HbO2 more difﬁcult. An absence of
intra-tumoural optoacoustic haemoglobin signal is ambiguous in
that it cannot be known whether such regions are truly avascular or
whether they are perfused but with a tissue blood volume that is
below the threshold of detection.
We hypothesise, therefore, that there would be value in
combining multispectral optoacoustic imaging with a co-regis-
tered sensitive perfusion imaging method for resolving such
ambiguity. In addition, such a combinative imaging approach may
be useful for gaining a more complete understanding of the
hypoxic state of the tumour. For example, tumour vascular
perfusion characteristics might one day be combined with local
blood oxygenation estimates using an oxygen transport model
[24], to enable estimation of the local partial pressure of oxygen
within the tumour cell environment.
To test this hypothesis we chose to combine multispectral
optoacoustic imaging with microbubble based dynamic contrast
enhanced ultrasound (DCE-US). It is practical to combine these
modalities since they both use ultrasound and can be implemented
on the same hardware. Moreover, microbubbles can be used to
image the vasculature at the microscopic scale [25,26] and their
size makes them behave like erythrocytes, effectively preventing
their extravasation from the fenestrated microvasculature, making
DCE-US sensitive solely to the vascular perfusion characteristics,
whereas alternatives such as contrast enhanced (CE-) MSOT [27],
DCE-MRI [28] or DCE computed tomography (CT) [28] use contrast
agents (indocyanine green, iodine or gadolinium, respectively)
[29] that move between the vascular and interstitial compart-
ments. The study might also have been performed using CE-MSOT,
or even DCE-MRI or DCE-CT, utilising contrast agents that would
remain intravascular, such as microbubbles loaded with dye
molecules [30], gadolinium [31] and gold nanoparticles [32],
respectively. Such agents, however, remain in the research domain
and are not readily available, whereas microbubbles are conve-
niently and commercially available, licensed for use in clinical
ultrasound, and modern nonlinear signal processing makes
ultrasound scanners extremely sensitive to their presence (even
detecting a single microbubble at a depth of many centimetres in
tissue [26]). These provided the main reasons why DCE-US was
chosen for the present study, knowing that the ﬁndings should be
applicable to other contrast enhanced imaging modalities given a
suitable contrast agent. A further advantage of studying the
relationship between MSOT and DCE-US, rather than between
MSOT and contrast enhanced MSOT, MRI or CT, is the potential for
unanticipated discoveries which have useful consequences.
Speciﬁcally, although it was not an aim of this study, if correlations
between MSOT and DCE-US features were to be discovered, this
may suggest a way to translate the use of valuable MSOT image
information into the clinic in situations, such as when imaging
deep within the body, where MSOT can not be employed.Although previous studies have compared DCE-US with
multispectral optoacoustic imaging in animal tumours [33–36],
none have investigated the above hypothesis nor explored the full
range of microbubble-based perfusion properties such as time of
arrival, time to peak, wash-in time, peak contrast, area under the
curve (AUC), wash-in rate and wash-out rate with SaO2 and HbT.
The aims of this study were twofold: (i) to assess whether regions
in optoacoustic images lacking an identiﬁable blood spectral
signature are indeed avascular, (ii) to determine whether there are
relationships between the properties obtained using the two
imaging approaches.
An MSOT inVision 256-TFTM (iThera Medical, Munich) was used
for optoacoustic imaging because of its real-time full spectral and
whole mouse cross-sectional imaging ability, and a clinical scanner
(Aplio XGTM, Toshiba, Tokyo) was used for DCE-US so that ﬁndings
from the study may have the potential for direct clinical translation
and full advantage can be taken of commercially available
microbubble agents, which as yet are not available for high-
frequency ultrasound imaging [37]. As a consequence, the study
required the development of a novel experimental apparatus and
scanning method to assist the process of co-registering image data
between the two systems, which is also described in this paper.
2. Methods
2.1. Cell lines
Two pancreatic tumour models were chosen because they
possess a heterogeneous vasculature with hypoxic regions [38–
40]. The cell line, PDA-KPC-1 GEMM, derived from KPC mice, a
genetically engineered pancreatic ductal adenocarcinoma model,
was obtained from the University of Pennsylvania (Philadelphia,
USA) [41]. The carcinoma cell line, MIA PaCa-2, was obtained from
ATCC. Cells were grown in Dulbecco's Modiﬁed Eagle Medium,
supplemented with 10% foetal bovine serum, in a humidiﬁed
atmosphere of 5% CO2 in air at 37 C.
2.2. Tumour model
Groups of female CrTac:NCr-Fox1nu athymic nude mice,
approximately 6 weeks of age, were injected subcutaneously on
the right ﬂank with either 3 million PDA-KPC-1-GEMM cells (n = 2)
or 5 million MIA PaCa-2 cells (n = 3). The animals were imaged
when the tumour volume reached about 500 mm3.
2.3. Optoacoustic imaging
Optoacoustic imaging was performed using a commercially
available pre-clinical tomographic whole-body imaging system,
MSOT inVision 256-TFTM. As stated by the manufacturer, the
imaging system contains a partial ring array of 256 transducer
elements, each with a centre frequency of 5 MHz and a bandwidth
of greater than 60%. The array covers a reception angle of 270. The
animal to be imaged was anaesthetised using an intraperitoneal
injection of fentanyl, midazolam and medetomidine in distilled
water (ratio of 2:2:1:5, 10 mL/kg) and the tail vein was catheterised
using a catheter fabricated in the laboratory. The animal was then
placed in acoustic coupling gel in an animal holder consisting of a
nose cone for air supply and a polyethylene membrane, which was
then submerged in the water tank of the system, maintained at
34 C. The animal in the holder was illuminated with multiple 10 ns
pulses of laser light, at a pulse repetition interval of 100 ms, each
pulse at a different wavelength ranging from 710 nm to 950 nm, at
intervals of 10 nm. In order to create a cross-sectional image at one
wavelength, optoacoustic signals generated by the tissue from 10
pulses were averaged. The signals were reconstructed using a
A. Shah et al. / Photoacoustics 8 (2017) 15–27 17model-based inversion algorithm [42] (ViewMSOTTM v 3.6). The in-
plane resolution of such images has been measured to be of the
order of 150 mm (measured by iThera Medical). The animal was
then translated along its long axis in steps of 1 mm to obtain
additional cross-sectional images which together covered the
whole tumour. The slice-thickness resolution has been measured
to be about 800 mm (measured by iThera Medical).
2.4. Ultrasound imaging
After optoacoustic imaging, for DCE-US imaging, the anaes-
thetised animal in its holder was transferred undisturbed to a
purpose-built gantry, designed to replicate the way that the holder
is supported in the MSOT imaging system. As shown in Fig. 1 the
gantry consisted of a water-bag standoff replicating the water tank
setting of the animal holder in the MSOT system. The animal in the
animal holder was submerged in the water warmed to a
temperature of 34C. Maintaining the animal in its original holder,
and submerged in water, restricted changes in posture and
orientation of the tumour. The animal’s body temperature was
maintained during the imaging process using a heating lamp. A
1204BT linear array probe (Toshiba Aplio XGTM clinical US scanner)
was mounted beneath the animal holder and water bag on a
mechanical stage, pointing upwards to image the animal in cross-
section. The ultrasound probe was translated mechanically along
the long axis of the animal in steps of 1 mm to cover the whole
tumour. After an initial full mechanical scan to record the tumour’s
echo anatomy, the transducer was aligned to the cross-section of
the tumour having maximum area. 100 mL of SonazoidTM micro-
bubbles [43] was then injected through the catheter. Interleaved
non-linear contrast mode and fundamental B-mode images were
recorded at a frame rate of 10 Hz for up to 40 s. Non-linear contrast
mode images were obtained by the scanner’s proprietary pulse-
subtraction coded harmonic technique with a mechanical index of
less than 0.3 and a dynamic range setting of 65 dB.
2.5. Data analysis
Prior to optoacoustic image analysis, any negative value pixels
arising as a result of noise or reconstruction errors were assigned aFig. 1. The DCE-US imaging apparatus which replicates the arrangement used to
support the animal holder in the MSOT inVision 256TM and thus provides a good
basis for subsequent registration between ultrasound and optoacoustic images. The
red cast in the image is due to the heating lamp in place to maintain the animals core
temperature. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)value of zero. Under the assumption of no position or wavelength
dependent ﬂuence variation due to light attenuation, the
reconstructed data were spectrally unmixed using linear regres-
sion (ViewMSOTTM v 3.6) to resolve the Hb and HbO2 components
in the optoacoustic image. For every pixel in the reconstructed
image, the unmixing algorithm models the observed optoacoustic
spectrum as a linear combination of the known spectra of Hb and
HbO2, to compute Hb and HbO2 images as the spatial distribution
of the relative concentration of each absorber [21,44,45]. Mean
SaO2 and mean HbT were then calculated for user-deﬁned regions
of interest (ROIs) within the tumour (see below) using the Eq. (1)
[46,47] and Eq. (2),
< SaO2 >¼
cHbO2
E
HbT;
*
ð1Þ
HbT
E
¼ cHb
E
þ cHbO2
E
;
DDD
ð2Þ
where cHbO2
ED
and cHb
ED
are the means over the ROIs of the
MSOT calculated concentrations of HbO2 and Hb respectively. An
“oxymap” image, showing the calculated SaO2 values for each
pixel, was also obtained, using the ViewMSOT software. This was
not used for calculating the mean SaO2 values in ROIs because it
was observed to be subject to pixel dropout and the software did
not account for the zero value pixels for calculating the mean
values of SaO2 in a region of interest.
The MSOT and DCE-US images having maximum tumour cross-
sectional area were assumed to correspond to a similar plane and
were registered manually as follows, utilising rigid body trans-
formations within Microsoft’s Expression Encoder 4TM (Microsoft,
Washington). First, the spectrally unmixed and oxymap images
were spatially rescaled, maintaining the aspect ratio, to match the
10 mm scale bar to that of the DCE-US image. After rescaling, the
MSOT images were rotated and translated so that the tumour
boundary and any major blood vessels observed in the single
wavelength image at 800 nm (isosbestic point of Hb and HbO2)
matched those of the non-contrast and contrast ultrasound
images. Blood vessels were made more visible in the contrast
mode ultrasound images by subtracting the pre- and post-
microbubble injection sequences (examples are shown later in
Figs. 4(E) and 5(E), encircled by a red boundary). The spectrally
unmixed and oxymap images were translated and rotated to the
same degree. Rigid body-transformations were assumed sufﬁcient
for registering the two imaging modalities because the animal was
maintained in its original holder and submerged in water, which
restricted changes in animal posture and orientation of the
tumour.
Regions of the tumour showing an absence of HbO2 and Hb on
the spectrally unmixed optoacoustic images were selected by
manual outlining to assess their perfusion characteristics with
DCE-US. Time intensity curves (TICs) were calculated as the mean
contrast signal within each ROI verses time, after background echo
image subtraction, using a program written in Matlab (2010b,
MathWorks, Natick, MA).
In order to further assess any potential relationship between
HbT and SaO2 values and DCE-US perfusion characteristics, ROIs
were selected in the periphery and in the body of the tumour
where the optoacoustic images showed a presence of blood, and
the same regions were selected on the DCE-US image sequences.
Seven properties were calculated from the TICs and compared with
SaO2 and HbT, as calculated optoacoustically. The peak contrast
(maximum contrast value attained by the TIC), time to peak (time
required for the microbubbles to reach the peak contrast) and the
18 A. Shah et al. / Photoacoustics 8 (2017) 15–27time of arrival (the intersection point between the baseline and a
tangent of the wash-in rise) of microbubbles for different regions
of the tumour were obtained by visually ﬁtting a smooth curve to
each TIC. The wash-in time was obtained as a difference between
the time to peak and time of arrival. The wash-in rate was
determined by measuring the slope of a straight line between the
peak contrast and contrast at the time of arrival. The wash-out rate
of microbubbles was calculated as the decay constant of an
exponential decay curve that was ﬁt to the TIC data between the
time of peak contrast and the 40 s time point.
To estimate and assess the relationships of SaO2 and HbT to
DCE-US properties, two types of analyses were carried out. First, a
within-tumour analysis was conducted in which, for each tumour,
the correlation between each optoacoustic and each DCE-US image
property was evaluated. For each tumour and each pair of
properties, the mean property value was calculated in each ROI,
after which the Pearson correlation coefﬁcient was calculated over
the number of ROIs in that tumour. This allowed the relationships
between the optoacoustic and the DCE-US properties to be
assessed without the confounding effect of inter-tumour variation.
However, the signiﬁcance of any such correlations, if present,
would inevitably be low because the number of ROIs in each
tumour was never more than seven, and was sometimes as few as
four. Therefore the signiﬁcance of the within-tumour correlation
coefﬁcients was assessed by studying their consistency across all of
the tumours, as revealed by a Student’s t-test applied to the means
and standard deviations (across tumours) of the within-tumour
correlation coefﬁcients for each pair of properties.
Second, the correlation between each optoacoustic and each
DCE-US property was evaluated using all ROIs for all tumours.
Here, the correlations were expected to be low, and of low
signiﬁcance, because of the confounding inﬂuence of inter-tumour
variations. Therefore, this analysis was repeated after applying an
approximate correction method, the objective of which was to
estimate the values of the correlation coefﬁcients that would be
expected if there were no inter-tumour variation. This correction
method began by calculating for each mouse the slope aMi andFig. 2. A) A reconstructed single wavelength MSOT image of mouse M1 (example of a 
corresponding spectrally unmixed image, showing the distribution of Hb and HbO2 comp
of the SaO2 values. The yellow scale bar at the lower-left in each of these images is 5 mm
spectral signature of blood. The background, Hb, HbO2 and oxymap colour bars reﬂect the
SaO2, respectively, as calculated by the MSOT system. (For interpretation of the referen
article.)intercept bMi in the least squares best ﬁt of the linear model
(y = aMix + bMi) for the variation of image property y with image
property x over the tumour ROIs for that mouse. The mean slope a
and mean intercept b over all such ﬁts for all mice were then
calculated using:
a ¼ 1
N
XN
i¼1
aMi b ¼
1
N
XN
i¼1
bMi; ð3Þ
where N is the total number of mice.
A corrected data point, corrected for the departure of a given
mouse’s best ﬁt linear relationship from the average relationship,
was computed for each data point corresponding to each ROI using
Eq. (4):
yMi;k correctedð Þ ¼ yMi;k þ y  yMiÞ;ð ð4Þ
where y ¼ axk þ b and yMi = aMixk+ bMi, and k is the ROI number for
the mouse. New correlation coefﬁcients rcorrected, and their
corresponding p values, were calculated using these corrected data
points.
The AUC, correlation coefﬁcients and corrections for between-
tumour variations were calculated using PrismTM version 7
(GraphPad, San Diego). Means and standard deviations, and
statistical assessments using Student’s t-test, were calculated
using Microsoft Excel1 2007TM.
3. Results
3.1. Optoacoustic imaging
For both tumour models, the optoacoustic signals found at the
periphery of the tumours were typically stronger than those found
in the tumour body; examples are shown in Figs. 2 A and 3 , A. In
order to allow the variations in image appearance between mice to
be better appreciated, image sets from two additional mice (M2
and M4) are provided in Figs. S1 and Fig. S2, respectively, in the
supplementary section. Spectral unmixing revealed a strongPDA-KPC tumour) at 800 nm. The dashed yellow line indicates the tumour. B) The
onents in blue and red respectively. C) The oxymap image, showing the distribution
. The yellow arrows in images B and C indicates the centre of a region that lacks any
 magnitude of the photoacoustic signals, deoxy-haemoglobin, oxy-haemoglobin and
ces to colour in this ﬁgure legend, the reader is referred to the web version of this
Fig. 3. A) A reconstructed single wavelength MSOT image of mouse M3 (example of MIA PaCa-2 tumour) at 800 nm. The dashed yellow line indicates the tumour. B) The
corresponding spectrally unmixed image, showing the distribution of Hb and HbO2 components in blue and red respectively. C) The oxymap image, showing the distribution
of the SaO2 values. The yellow scale bar at the lower-left in each of these images is 5 mm. The yellow arrows in images B and C indicates the centre of a region that lacks any
spectral signature of blood. The background, Hb, HbO2 and oxymap colour bars reﬂect the magnitude of the photoacoustic signals, deoxy-haemoglobin, oxy-haemoglobin and
SaO2, respectively, as calculated by the MSOT system. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
A. Shah et al. / Photoacoustics 8 (2017) 15–27 19presence of HbO2 in the periphery of the tumours (Figs. 2B and 3B),
corresponding to a high SaO2 value (Figs. 2C and 3C). The body of
the tumours had a higher proportion of Hb in comparison to the
periphery (Figs. 2B and 3B), corresponding to a low SaO2 value. The
PDA-KPC tumour showed an absence of Hb/HbO2 signal in its core,
as evidenced by black regions and marked by arrows in Fig. 2B and
C. The MIA PaCa-2 tumour illustrated showed heterogenous
vascularisation in its body, with an absence of blood signal in three
segments, as indicated by arrows in Fig. 3C.
3.2. Contrast mode imaging and registration with optoacoustic
imaging
In order to assess whether tumour regions having no blood
signal on optoacoustic imaging also lacked observable perfusion on
DCE-US, ROIs were drawn around black regions on the opto-
acoustic Hb:HbO2 image, such as the core of the PDA-KPC tumour
in Fig. 4(D) (dashed green and dark green) and in the three
different segments of the tumour MIA PaCa-2, as seen in Fig. 5(D)
(top-left dark region (green colour), top-right dark region (brown)
and bottom dark region (pink)). The same ROIs were applied to the
DCE-US image sequences to obtain TICs (Figs. 4F and 5F) and
evaluate the perfusion characteristics.
Figs. 4C and 5C show the spectrally unmixed MSOT images as
transparent overlays on the DCE-US images of the same example
PDA-KPC and MIA PaCa-2 tumours as shown in Figs. 2 and 3,
respectively. The contrast mode ultrasound images of the tumours
before and after microbubble injection are shown in Fig. 4A and B,
for the PDA-KPC tumour case, and Fig. 5A and B, for the MIA PaCa-2
tumour case.
In order to assess whether the microbubble perfusion proper-
ties were correlated in general with SaO2 and HbT values, ROIs
were also selected in other parts of the tumour and in a feeding
blood vessel. Example ROIs are illustrated in Fig. 4D in red (blood
vessel), dashed purple (upper rim), orange (upper body), anddashed cyan (lower rim), and Fig. 5D in red (blood vessel), dashed
purple (upper rim), dashed yellow (inner blood vessel), and dashed
cyan (lower rim).
Figs. 4E and 5E show the overlays of the selected ROIs on the
microbubble post-injection contrast-mode US images at time
points of 10, 15 and 40 s, after subtraction from the pre-injection
image. As seen in Figs. 4E and 5E, the microbubbles arrive ﬁrst at
the feeding blood vessel at a time point t  10 s, and subsequently
arrive in other parts of the tumour. As seen in mouse M1 (PDA-KPC)
in Fig. 4, the tumour core, lacked a blood signal in the MSOT image
(Fig. 4D) and was echogenic on US before contrast injection
(Fig. 4A), was perfused on DCE-US, albeit with a low blood volume
and speed (Fig. 4E (t = 40s) and 4F, dashed green curve). Similarly,
in mouse M3 (MIA PaCa-2) in Fig. 5, the three black regions
(Fig. 5D) were highly perfused, as can be seen from the background
subtraction image at t = 40 s (Fig. 5E) and TICs of the dark regions in
Fig. 5F. Similar results were observed in all tumour cases. These
results clearly demonstrate the value of combining the two
imaging modalities, to differentiate the poorly perfused regions of
the tumour from those having no perfusion, which is difﬁcult to
observe with MSOT alone.
3.3. Relationships between microbubble dynamic properties and blood
content and oxygenation
For the within-tumour analysis, as seen in Fig. 6A and C, there
was a consistent negative correlation of SaO2 and HbT with the
time of arrival, time to peak and wash-in time. Similarly, SaO2 and
HbT were positively correlated in almost all mice with peak-
contrast, wash-out rate, wash-in rate and AUC, there being one
exception, a negative correlation of HbT with AUC in mouse M1
(PDA-KPC). Since a limited number of ROIs (4–7) were selected for
calculating these correlation coefﬁcients, only a few were
signiﬁcant at the p = 0.05 level (indicated by an asterisk in
Fig. 6A and C). However, signiﬁcance is established because of
Fig. 4. (A) An ultrasound image of the M1 (PDA-KPC) tumour before microbubble injection. B) The ultrasound image of the tumour 40 s after microbubble injection. C) An
overlay of the spectrally unmixed optoacoustic image from Fig. 2B on the ultrasound image from (A) after rigid registration of the two images. D) The graphic overlay on (C) to
indicate the regions of interest analysed, colour coded as red (blood vessel), dashed purple (upper rim), orange (upper body), dashed light green (core), dark green (lower
body) and dashed cyan (lower rim). (E) Microbubble post-injection contrast-mode US images at time points of 10, 15 and 40 s respectively, after subtraction from the pre-
injection image. (F) The time intensity curves obtained by analysing the DCE-US data according to the regions of interest shown in (D). (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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tumours; as shown in Fig. 6B and D, the mean correlation
coefﬁcients were signiﬁcantly different from zero for all but one
optoacoustic and DCE-US combination.Results for the cross-tumour analysis without accounting for
the inter-tumoural variation of the measurements are shown in
Figs. 7–9. These results have been grouped so as to show the
observed negative correlations in Fig. 7, positive correlations
Fig. 5. A) An ultrasound image of the M3 (MIA PaCa-2) tumour before microbubble injection. B) The ultrasound image of the tumour 40 s after microbubble injection. C) An
overlay of the spectrally unmixed optoacoustic image from Fig. 3B on the ultrasound image from (A) after rigid registration of the two images. D) The graphic overlay on (C) to
indicate the regions of interest analysed, colour coded as red (blood vessel), dashed purple (upper rim), green (top left dark region), brown (top right dark region), dashed
yellow (inner blood vessel), pink (bottom dark region) and dashed cyan (lower rim). E) Microbubble post-injection contrast-mode US images at time points of 10, 15 and 40 s
respectively, after subtraction from the pre-injection image. (F) The time intensity curves obtained by analysing the DCE-US data according to the regions of interest shown in
(D). (G) The time intensity curves obtained by analysing the DCE-US data in the three black regions according to the regions of interest shown in (D). (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
A. Shah et al. / Photoacoustics 8 (2017) 15–27 21involving DCE-US blood volume measures in Fig. 8 and positive
correlations involving DCE-US rate measures in Fig. 9.
Referring to Fig. 7, signiﬁcant negative correlation was observed
between SaO2 and DCE-US derived microbubble time of arrival
(r = 0.5629, p = 0.0015), time to peak (r = 0.597, p = 0.0006) and
wash-in time, (r = 0.4966, p = 0.0061). HbT also showed a negative
correlation with time of arrival (r = 0.4743, p = 0.0093), time to
peak (r = 0.3625, p = 0.0533) and wash-in time (r = 0.239,
p = 0.2117). However, the correlation coefﬁcients involving HbT
were consistently lower than those involving SaO2, and were not
signiﬁcant for time to peak and wash-in time.
Signiﬁcant positive correlation was observed between HbT and
the DCE-US blood volume TIC properties (AUC and peak contrast).
As seen in Fig. 8, the correlations between HbT and AUC (r = 0.4059,p = 0.0289) and peak contrast (r = 0.4944, p = 0.0064) were stronger
and more signiﬁcant than those involving SaO2 with AUC
(r = 0.3411, p = 0.0702) and with peak contrast (r = 0.3083,
p = 0.1038).
Signiﬁcant positive correlations were observed between micro-
bubble wash-in rate and both SaO2 (r = 0.5294, p = 0.0031) and HbT
(r = 0.4313, p = 0.0195). Although positive correlations were also
seen between microbubble wash-out rate and SaO2 (r = 0.2854,
p = 0.1334) and HbT (r = 0.3584, p = 0.0563), neither was signiﬁcant
at the p = 0.05 level.
A summary of the correlation coefﬁcients from Figs. 7–9, and
their signiﬁcance, is shown in Fig. 10. The signiﬁcance levels after
correcting for inter-tumoural variations (Section 2.5) are indicated
as red asterisks in brackets in Fig. 10. This approximate attempt to
Fig. 6. (A) The correlation coefﬁcients for SaO2 with each DCE-US characteristic for individual tumour cases (B) The means and standard deviations of the intra-tumour
correlations shown in (A). (C) The correlation coefﬁcients for HbT compared with each DCE-US characteristic for individual tumour cases. (D) The means and standard
deviations of the intra-tumour correlations shown in (C). The asterisk signs indicate the signiﬁcance level for there being no correlation (* (p  0.05), ** (p  0.01), ***
(p  0.001), **** (p  0.0001)).
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of the 14 correlations (particularly the time based TIC properties),
had no effect on the signiﬁcance of 5 and decreased the
signiﬁcance in 2. The scatter plots of the relationships between
the optoacoustic imaging and the microbubble DCE-US character-
istics, after correcting for the inter-tumoural variability (Figs. S3, S4
and S5) have been included in the supplementary section.
4. Discussion
To our knowledge, this is the ﬁrst time that a combinative
imaging approach of optoacoustic imaging and DCE-US has been
applied to an automated whole-body mouse tomographic opto-
acoustic imaging system, the MSOT inVision 256–TF, which lacks
the capability to perform microbubble contrast enhanced ultra-
sound imaging. For all ﬁve tumours, it was observed that certain
tumour regions that showed no optoacoustic blood signal were
perfused on DCE-US. Similar ﬁndings can be expected with CE-
MSOT using a contrast agent that does not extravasate. A low blood
volume (as indicated by a low microbubble uptake on DCE-US),
below the optoacoustic detection threshold of the imaging system,
seems to be a plausible explanation. These tumours are not prone
to contain confounding absorbers; nor does it seem likely that the
light attenuation in the subcutaneous tumours would be a
contributing factor, that would obscure the recognition of
haemoglobin. Nevertheless, to improve the spatial homogeneity
and quantiﬁcation of tumour SaO2 and HbT, incorporating analgorithm to estimate the wavelength and depth-dependent light
attenuation would be helpful. Tzoumas et al. [21] recently
developed an approach to incorporate wavelength-dependent
light attenuation to estimate blood SaO2 within deep tissue with
more accuracy, using the MSOT system. Work in this area is
underway. An alternative (hypothetical) explanation for the above
observation is that the microbubbles, given their smaller size than
red blood cells, were reaching areas of the tumour not accessible to
the blood cells.
The SaO2 values were found to be negatively correlated with
DCE-US time of arrival and time to peak with a high level of
signiﬁcance (Fig. 7). This implies that the intravascular micro-
bubbles follow the path of the red blood cells. As the oxygenated
blood travels from the feeding vessels to the microvasculature of
the tumour, the blood SaO2 should decrease on the path taken by
the red blood cells. The extent of the decrease in SaO2 would
depend on the metabolic activity and demand for oxygen, which
would be considerable for the periphery of the tumour in
comparison with its hypoxic core [48]. A similar correlation was
also observed with HbT, although with a lower correlation
coefﬁcient and a lower level of signiﬁcance.
HbT was positively correlated with AUC and peak contrast
(Fig. 8). These correlations were expected as HbT, peak contrast
and AUC are all dependent on the local blood volume. This ﬁnding
broadly conﬁrms the results (a) of Zion et al. [33], who observed a
positive correlation of AUC with HbT in PC3 human prostate
carcinoma xenograft models, and (b) of Eisenbrey et al. [36], who
Fig. 7. Variation of SaO2 (left column) and HbT (right column) with microbubble time of arrival (top), time to peak (middle) and wash-in time (bottom). Correlations between
SaO2 and these DCE-US TIC properties were stronger and more signiﬁcant than those between HbT and the DCE-US TIC properties. The p values indicate the probabilities that
the correlation coefﬁcients (r) are zero. Symbols represent individual mice: M1(PDA-KPC), M2(PDA-KPC), M3(MIAPaCa-2), ! M4(MIAPaCa-2), M5(MIAPaCa-2). The
indicative linear regression line is to aid visual interpretation of the strength of correlation and is not intended to imply that a linear relationship exists.
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(r = 0.49, p = 0.021). Given that Zion et al. and Eisenbrey et al. used
different tumours, a different microbubble contrast agent and
different ultrasound and optoacoustic imaging systems to those
employed here, this conﬁrmation of ﬁndings lends credance to
their results and ours, and increases conﬁdence in other ﬁndings
reported only here.
A signiﬁcant positive correlation of SaO2 and HbT with wash in
rate of microbubbles was observed (Fig. 9). The wash-in and the
wash-out rates are related to blood velocity. The red blood cells
would have a higher velocity in the peripheral tumoural blood
vessels offering less resistance than the tortuous tumour vascula-
ture accompanied by a high interstitial pressure, commonly
present in the interior of the tumour [49]. Regions of the tumour
showing a high SaO2 and HbT value, predominantly in the
periphery, showed a higher wash-in rate in comparison to the
regions having low SaO2 and HbT values. A moderately positive
correlation of SaO2 and HbT with the wash-out rate was also
observed, although it was not statistically signiﬁcant. The transit
time, the total time for the bubbles to pass a particular position,was not measured because we did not allow time for the bubble
contrast signal to return to baseline. This suggests the need for
further work to observe microbubbles for longer periods. However,
the sum of wash-in rate and wash-out rate could be regarded as
directly related to the inverse of transit time, and a negative
correlation between SaO2 and HbT with the microbubble transit
time can therefore be expected.
The correlations observed between the optoacoustic and DCE-
US properties of different tumour regions suggest that a
combination of low microbubble signal, late microbubble arrival
and slow microbubble transit should be predictive of low oxygen
saturation. This remains to be tested but suggests new roles for
DCE-US in providing surrogate measures of oxygenation levels,
which may be of value for example in predicting radiation and drug
treatment effectiveness in clinical situations where a tumour to be
treated is too deep to be imaged optoacoustically.
In order to assess whether the correlation coefﬁcients, along
with their signiﬁcance, may have been decreased by inter-
tumoural variations in the functional relationship between image
properties, a difference between the overall mean relationship for
Fig. 8. Variation of SaO2 (left column) and HbT (right column) with microbubble AUC (top) and peak contrast (bottom). Correlations involving HbT were stronger and more
signiﬁcant than those involving SaO2. The p values indicate the probabilities that the correlation coefﬁcients (r) are zero. Symbols represent individual mice: M1(PDA-KPC),
M2(PDA-KPC), M3(MIAPaCa-2), ! M4(MIAPaCa-2), M5(MIAPaCa-2). The indicative linear regression line is to aid visual interpretation of the strength of correlation
and is not intended to imply that a linear relationship exists.
Fig. 9. Variation of SaO2 and HbT with microbubble wash-in and wash-out rates. Signiﬁcant correlations were observed for SaO2 and HbT with wash-in rate. The correlations
of SaO2 and HbT with wash-out rate were not signiﬁcant at the 0.05 level. The p values indicate the probabilities that the correlation coefﬁcients (r) are zero. Symbols
represent individual mice: M1(PDA-KPC), M2(PDA-KPC), M3(MIAPaCa-2), ! M4(MIAPaCa-2), M5(MIAPaCa-2). The indicative linear regression line is to aid visual
interpretation of the strength of correlation and is not intended to imply that a linear relationship exists.
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Fig. 10. Summary of the observed correlations of optoacoustic imaging properties SaO2 (A) and HbT (B) with DCE-US characteristics for all ROIs in all tumours. Asterisks
indicate statistically signiﬁcant correlations before (black) and after (red bracket) accounting for inter-tumoural variation at levels: * p < 0.05, ** p < 0.01, *** p < 0.001, ****
p < 0.0001. A non-signiﬁcant correlation at the p = 0.05 level is denoted by (ns). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.)
A. Shah et al. / Photoacoustics 8 (2017) 15–27 25a pair of image properties (over all ROIs and all tumours) and that
for all ROIs for a tumour was obtained, and used to obtain a
correction factor that was subtracted from each dependent image
property value in a pair, for each individual tumour. The resulting
changes in correlation coefﬁcients and their signiﬁcance, as
indicated in brackets (red) in Fig. 10, suggest that inter-tumoural
variation was important in some relationships and not others. It
would therefore be worthwhile continuing such studies with
increased statistical power as described in the following para-
graph.
A limitation of the present study was that the registration of the
MSOT and US images was dependent on the author’s judgement of
the matching features in the two sets of images, and of ﬁnding an
MSOT image that matched the DCE-US imaging plane. Such
registration may vary from user to user. Importantly for the present
study, its limited accuracy prevented a pixel by pixel correlation
between the optoacoustic and DCE-US image properties of the type
achieved by Zion et al. [33], which was possible in their case
because they used hardware in which optoacoustic and ultrasound
imaging were implemented with the same transducer. This limited
the statistical power of our intra-tumoural analyses since large
ROIs had to be used, restricting the number of ROIs per tumour to
between four and seven. Repeating this study using simultaneous
optoacoustic and DCE-US imaging with the same transducer
should signiﬁcantly reduce this source of variation, allowing
greatly improved statistical power when assessing the intra-
tumoural relationships between image characteristics. It also
provides motivation for investigating the use of automated
registration methods, implementing DCE-US on the MSOT system
and the development of 3D DCE-US. The study is also limited by the
absence of histological conﬁrmation of regions of the tumours
lacking a blood signature on MSOT. From this study, no conclusions
can be drawn regarding the histological nature of such regions, e.g.
the condition of the endothelium, or whether the cells there are
hypoxic, necrotic or apoptotic. In fact, there is a general need for
studies that use histological markers as a reference standard for
assessing blood and oxygen saturation using optoacoustic images;
work in this area has just begun [50]. However, the absence of such
conﬁrmation in the present study does not detract from our ﬁnding
that in some dark regions, as imaged by MSOT, the tissue was
perfused.Finally, for preclinical combined modality research using the
iThera MSOT inVisionTM, the novel registration system described
may be of more general interest, for registering MSOT images to
various ultrasound images such as B-mode, microbubble, Doppler
and elastography, as well as for registering to high intensity
ultrasound and other therapeutic devices. Additional uses may
include the optoacoustic localisation (e.g. for targeting with
physical therapies) of orthotopic tumours grown from cell lines
that have been genetically modiﬁed to express proteins that are
spectroscopically identiﬁable by MSOT.
5. Conclusion
There is value in combining optoacoustic spectral imaging with
dynamic contrast ultrasound imaging when studying tumour
hypoxia. For example, combining the two imaging modalities
allows DCE-US to assist interpretation of the optoacoustic images,
as demonstrated here where DCE-US helped to answer the
question of whether a region that lacks an optoacoustic blood
signal is perfused. Eventually, data from a vascular haemodynamic
property measurement method such as microbubble ultrasound
may be combined with blood oxygenation and haemoglobin
concentration measures from a method such as optoacoustic
imaging, in a model-based estimation of the hypoxic status of
cancer cells in speciﬁc regions of a tumour [23].
If further work conﬁrms that DCE-US properties are predictive
of low blood oxygen saturation, this ﬁnding would suggest
potential to use DCE-US characteristics as surrogates for blood
oxygen saturation, in predicting radiation and drug treatment
effectiveness in clinical situations when tumours are located too
deep for optoacoustic imaging to be used.
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